Remove 2050 Remove Cannabinoids Remove Safety Remove THC
article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

A notable example of this is the so-called ‘zero tolerance’ drug driving legal frameworks, which criminalise the presence of THC (tetrahydrocannabinol) in a driver’s bodily fluids irrespective of impairment. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia.

Policy 66
article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia. Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. Road safety. Medicinal cannabis. Drug driving.

article thumbnail

Benefits of Cannabis for Alzheimer’s disease

Alchimia

Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. They protect neurons – although many media state the opposite – since cannabinoids are not neurotoxic (compared to alcohol, nicotine and some medicines). Source: Spanish Society of Neurology ).